> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# No-Longer-Marketed Entereg’s Approval Withdrawn
- URL: https://www.fdaweb.com/no-longer-marketed-enteregs-approval-withdrawn/
- Published: 2024-08-15T12:00:00.000Z
- Updated: 2026-09-14T14:38:31.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5157578

*Federal Register* notice: FDA is withdrawing approval of Cubist Pharmaceuticals’ Entereg (alvimopan) capsules, 12mg, after the company notified the agency that the product was no longer marketed. Entereg is indicated for accelerating the time to upper and lower gastrointestinal recovery following partial large or small bowel resection surgery. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2024-08-15/pdf/2024-18269.pdf?ref=fdaweb.com).